<DOC>
<DOCNO>
EP-0006628
</DOCNO>
<TEXT>
<DATE>
19800109
</DATE>
<IPC-CLASSIFICATIONS>
C07D-213/65 A61K-31/4418 <main>C07D-213/75</main> A61P-9/00 C07D-213/75 C07D-213/68 A61P-9/12 C07D-213/73 A61K-31/44 A61K-31/4425 C07D-213/00 
</IPC-CLASSIFICATIONS>
<TITLE>
substituted dihydropyridine ureas, process for preparing the same and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.  <sep>
</APPLICANT>
<INVENTOR>
fisher michael herbert<sep>ruyle william vance<sep>fisher, michael herbert<sep>ruyle, william vance<sep>fisher, michael herbert1140 concord drivebirdgewater, n.j. 08807us<sep>ruyle, william vance1481 rahway roadscotch plains, n.j. 07076us<sep>fisher, michael herbert<sep>ruyle, william vance<sep>fisher, michael herbert1140 concord drivebirdgewater, n.j. 08807us<sep>ruyle, william vance1481 rahway roadscotch plains, n.j. 07076us<sep>
</INVENTOR>
<ABSTRACT>
compounds having the formula    and pharmaceutically acceptable salts thereof wherein   x is h, c₁-c₆ alkyl, cn, halo, sr or -or wherein r is  c₁-c₆ alkyl,   x¹ is h, c₁-c₆ alkyl, cn, halo, sr¹ or or¹ wherein r¹ is  c₁-c₆ alkyl,   y is h, halo, c₁-c₆ alkyl, cn, cf₃, no₂, cooc₁-c₆ alkyl,  nr²r³ wherein r² and r³ are h or c₁-c₆ alkyl, sr⁴,  sor⁴, so₂r⁴ or or⁴ wherein r⁴ is c₁-ch alkyl and   y¹ is h, halo, c₁-c₆ alkyl, cn, cf₃, no₂, cooc₁-c₆ alkyl,  nr²r³ wherein r² and r³ are h or c₁-c₆ alkyl, sor⁴,  so₂r⁴ or or⁴ wherein r⁴ is c₁-c₆ alkyl.  the compounds are useful as antihypertensive agents.  
</ABSTRACT>
</TEXT>
</DOC>
